Axcelis Technologies Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips... Show more
Axcelis Technologies shares have been consolidating in a narrow range, with the stock moving only modestly over the trailing 30 days. This relatively muted move contrasts with a stronger rally earlier in 2026 and reflects a market weighing improving order trends against still-pressured profitability. Semiconductor capital equipment names remain broadly supported by artificial intelligence-driven investment in memory and advanced packaging, yet Axcelis has underperformed parts of the sector as investors reassess margins and customer concentration.
Axcelis Technologies is a Massachusetts-based supplier of ion implantation systems, a critical step in semiconductor wafer fabrication. Its Purion platform—including the Purion H6 high-current system, the Purion XEmax high-energy system, and the Purion Power Series+—addresses applications across silicon carbide power devices, mature-node logic, memory, and advanced logic. The company has served the semiconductor industry for more than 45 years and also generates recurring revenue from its Customer Solutions & Innovation (CS&I) aftermarket business, covering parts, services, and system upgrades. Axcelis competes in a specialized equipment niche where it holds a differentiated position in high-energy implantation, and investors follow the stock closely as a lever on power semiconductor electrification and AI-driven memory capacity expansion.
On August 6, 2026, Axcelis reported second-quarter results that exceeded its own forecasts, with revenue of $215.2 million—up 10.6% year over year—and non-GAAP diluted earnings per share of $1.06. Management credited stronger system shipments and higher CS&I volume, and raised its full-year 2026 revenue expectation from roughly flat to mid-single-digit growth, with continued growth anticipated into 2027.
The quarter also highlighted margin pressure. Non-GAAP gross margin came in at 42.7%, down from 45.2% a year earlier, reflecting CS&I product mix and higher service costs. Systems bookings rose 36.1% to $130.9 million with a book-to-bill ratio near 1.0, but total backlog of $451.6 million remained well below the prior-year level of $575.7 million. China represented 46% of second-quarter revenue, and the top 10 customers accounted for roughly 68% of first-half revenue, underscoring concentration risk.
A defining near-term catalyst is the pending merger with Veeco Instruments, announced in late 2025 and approved by Axcelis stockholders in February 2026. The transaction remains subject to a final regulatory approval from China's State Administration for Market Regulation, with both companies expecting to close in the second half of 2026. Investor sentiment has also been shaped by the broader recovery in memory demand, where peers such as Applied Materials (AMAT) and Lam Research (LRCX) have pointed to AI-driven strength in high-bandwidth memory.
For traders seeking a systematic approach to market movements, Tickeron's Trending AI Robots page offers a curated view of its AI-driven trading bots. Tickeron provides hundreds of automated bots that trade thousands of tickers, but only the top-performing and most relevant strategies are featured in this section. These bots vary in strategy, timeframe, and performance metrics, giving users a way to explore data-driven approaches across different market conditions. The page is designed to help traders identify AI-powered tools that align with their own objectives, making it a practical starting point for those interested in algorithmic trading.
Axcelis enters the remainder of 2026 with a firmer demand backdrop and several variables still in play. For the third quarter, management guided to revenue of approximately $230 million and non-GAAP diluted EPS of about $1.11, with sequential growth expected into the fourth quarter. Memory remains the strongest growth vector as DRAM and high-bandwidth memory investment accelerates to support AI workloads, while silicon carbide power is showing signs of recovery, including new customer wins in China and demand for high-energy superjunction applications.
Key items to monitor include the timing and completion of the Veeco merger and any conditions tied to China's regulatory review, the trajectory of gross margin as memory—historically a lower-margin system segment—becomes a larger share of sales, and whether the general mature market's improving utilization translates into firmer orders. Backlog rebuilding, customer concentration, and China exposure remain important risks. Axcelis does not provide long-term financial targets beyond near-term guidance, and investors should focus on actual reported results rather than speculative projections.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where ACLS advanced for three days, in 258 of 307 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ACLS's RSI Indicator exited the oversold zone, 25 of 33 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 76%.
The Momentum Indicator moved above the 0 level on September 23, 2026. You may want to consider a long position or call options on ACLS as a result. In 68 of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 79%.
The Moving Average Convergence Divergence (MACD) for ACLS just turned positive on September 21, 2026. Looking at past instances where ACLS's MACD turned positive, the stock continued to rise in 36 of 50 cases over the following month. The odds of a continued upward trend are 72%.
ACLS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ACLS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 78%.
The Aroon Indicator for ACLS entered a downward trend on September 24, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 7 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 46 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.432) is normal, around the industry mean (8.033). P/E Ratio (39.742) is within average values for comparable stocks, (159.834). Projected Growth (PEG Ratio) (0.330) is also within normal values, averaging (0.816). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (3.733) is also within normal values, averaging (27.897).
The Tickeron Price Growth Rating for this company is 58 (best 1 - 100 worst), indicating fairly steady price growth. ACLS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 71 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ACLS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 63, placing this stock worse than average.
The Tickeron SMR rating for this company is 75 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of semiconductor equipment
Industry ElectronicProductionEquipment